Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
4.960
-0.200 (-3.88%)
Mar 20, 2026, 4:00 PM EDT - Market closed
Savara Market Cap
Savara has a market cap or net worth of $1.02 billion as of March 20, 2026. Its market cap has increased by 127.50% in one year.
Market Cap
1.02B
Enterprise Value
808.42M
1-Year Change
127.50%
Ranking
Category
Stock Price
$4.96
Market Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $1.02B, an increase of 664.96%. That is a compound annual growth rate of 25.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.02B | -17.26% |
| Dec 31, 2025 | 1.23B | 132.85% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
| Apr 28, 2017 | 132.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ORIC Pharmaceuticals | 1.09B |
| Septerna | 1.08B |
| Tevogen Bio Holdings | 1.08B |
| AbCellera Biologics | 1.07B |
| Pharming Group | 1.05B |
| Bicara Therapeutics | 1.01B |
| ArriVent BioPharma | 1.01B |
| Inhibrx Biosciences | 999.01M |